Some cancer types were excluded from the survival modelling because they have very high survival rates. These were testicular cancer, thyroid cancer, in situ cancers, thin melanomas (that is, invasive melanomas with a thickness less than 1 mm) and localised cancers (female breast, melanoma and prostate cancer).